Today's Paper Latest stories 🏈 High school scoreboard Obits Traffic Wally Hall Newsletters Weather Puzzles + games
ADVERTISEMENT
ADVERTISEMENT

Arkansas is to receive more than $1.5 million as part of a 38-state settlement with drug maker GlaxoSmithKline LLC over the way it promoted the use of the diabetes drug Avandia.

Arkansas Attorney General Dustin McDaniel on Monday announced the state took part in a $90 million settlement with the states.

Arkansas' share of the settlement is $1,557,495.30, according to the attorney general's website.

The company was accused of misrepresenting the risks of heart attack and stroke associated with Avandia.

The settlement requires GlaxoSmithKline to not make false, misleading or deceptive claims about any diabetes drugs.

Sponsor Content

Comments

You must be signed in to post comments
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT